%0 Journal Article
%T Treatment discordance in the utilization of neck dissection for stage I-II supraglottic tumors.
%A Gilja S
%A Vasan V
%A Kumar A
%A Roof SA
%A Genden EM
%A Kirke DN
%J Head Neck
%V 46
%N 7
%D 2024 Jul 14
%M 38482913
%F 3.821
%R 10.1002/hed.27736
%X <B>BACKGROUND: </B>In 2018, the National Comprehensive Cancer Network treatment guidelines began recommending the use of neck dissection during surgical management of stage I-II supraglottic laryngeal squamous cell carcinoma (LSCC).<BR><B>METHODS: </B>Trends and factors associated with the use of neck dissection during larynx-preserving surgery for patients with cT1-2, N0, M0 supraglottic LSCC in the National Cancer Database (2004-2020) were evaluated using multivariable-adjusted logistic regression.<BR><B>RESULTS: </B>Of the 2080 patients who satisfied study eligibility criteria, 633 (30.4%) underwent neck dissection. Between 2018 and 2020, the rate of neck dissection was 39.0% (114/292). After multivariable adjustment, academic facility type, undergoing biopsy prior to surgery, and more radical surgery were significant predictors of receiving neck dissection.<BR><B>CONCLUSIONS: </B>The results of this national analysis suggest that the utilization of guideline-concordant neck dissection for management of stage I-II supraglottic LSCC remains low and highlight the need to promote the practice of neck dissection for this patient population.